Clinical trial
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
NCT00462917 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00462917 |
|---|---|
| Title | REVEAL III: Risk Evaluation and Education for Alzheimer's Disease |
| Official title | Risk Evaluation and Education for Alzheimer's Disease |
| Acronym | REVEAL |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Human Genome Research Institute (NHGRI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Behavioral |
| Interventions | Pleiotropic info, in-person disclosure, AD-only info, phone disclosure |
| Enrollment | 290 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Apr 19, 2007 |
| Last update posted | Oct 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: